Insider Trading disclosures for Zenas Biopharma Inc.
The latest disclosure was made by Leon Moulder O. in Zenas Biopharma Inc. where a trade of 25,000
Common Stock done at an average price of $6.7
was reported to US exchanges on Feb. 18, 2025.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges